Is it time to change how we think about incomplete coronary revascularization?

Area of Science:

• Cardiology
• Vascular Surgery
• Interventional Cardiology

Background:

• The optimal extent of revascularization in chronic multivessel coronary artery disease (CAD) is a persistent clinical question.
• Historically, complete revascularization was considered superior, but incomplete revascularization is now recognized as a viable strategy for certain patient groups.
• Both percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) can achieve incomplete revascularization, though long-term results differ.

Discussion:

• Investigating the mechanisms behind the clinical benefits of incomplete revascularization is crucial.
• Understanding the factors contributing to the divergent long-term outcomes between PCI and CABG in incomplete revascularization scenarios is essential.
• Exploring the biological consequences of coronary reperfusion may offer insights into these discrepancies.

Key Insights:

• Incomplete revascularization is emerging as a potentially appropriate strategy in specific chronic multivessel CAD patient cohorts.
• Both PCI and CABG are feasible methods for achieving incomplete revascularization, but long-term clinical outcomes vary significantly between these approaches.
• Further research into the biological effects of coronary reperfusion is needed to elucidate the benefits and differences in incomplete revascularization strategies.

Outlook:

• Future research should focus on identifying patient subgroups who benefit most from incomplete revascularization.
• Comparative studies are needed to clarify the long-term efficacy and safety of PCI versus CABG for incomplete revascularization.
• Understanding the biological response to reperfusion could lead to refined revascularization strategies and improved patient outcomes in chronic CAD.